Overview

An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

Status:
ENROLLING_BY_INVITATION
Trial end date:
2026-02-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy (ability to produce a desired or intended result) of a topical product (applied to the skin) to improve skin lightness, skin condition and appearance (hyperpigmentation \[dark spots\], brightness/radiance \[healthy vibrant appearance\], skin texture \[smoothness\]) on \] the face over a period of eighteen (18) weeks. The data collected may support the company in developing marketing claims for its product.
Phase:
PHASE3
Details
Lead Sponsor:
Good Molecules, LLC
Collaborator:
Validated Claim Support